PRTN3 and rheumatoid arthritis: Similarly, the ongoing Arthritis Prevention in the Preclinical Phase of RA with Abatacept (APIPPRA) trial is another UK study which enrolled ACPA-positive individuals with arthralgias and is evaluating the effectiveness of subcutaneous abatacept in RA prevention (166).